Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX3WXY
|
||||
Drug Name |
(R)-5-(4-Benzoyl-piperidin-1-yl)-5-oxo-4-(3-m-tolyl-ureido)-pentanoic acid
|
||||
Synonyms |
CHEMBL101752
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H29N3O5
|
||||
Canonical SMILES |
Cc1cccc(NC(=O)N[C@H](CCC(=O)O)C(=O)N2CCC(CC2)C(=O)c3ccccc3)c1
|
||||
InChI |
InChI=1S/C25H29N3O5/c1-17-6-5-9-20(16-17)26-25(33)27-21(10-11-22(29)30)24(32)28-14-12-19(13-15-28)23(31)18-7-3-2-4-8-18/h2-9,16,19,21H,10-15H2,1H3,(H,29,30)(H2,26,27,33)/t21-/m1/s1
|
||||
InChIKey |
MCGMEEHYMPKNAM-OAQYLSRUSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.